We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$817M
AUM Growth
+$4.92M
Cap. Flow
+$2.1M
Cap. Flow %
0.26%
Top 10 Hldgs %
38.72%
Holding
1,198
New
61
Increased
125
Reduced
182
Closed
72

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$3.72M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.95M
3
V icon
Visa
V
+$2.77M
4
INTU icon
Intuit
INTU
+$2.24M
5
ADBE icon
Adobe
ADBE
+$1.42M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$4.07M
2
META icon
Meta Platforms (Facebook)
META
+$2.97M
3
KDP icon
Keurig Dr Pepper
KDP
+$2.09M
4
AMZN icon
Amazon
AMZN
+$1.57M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.41M

Sector Composition

Rank Sector Weight
1 Financials 22.61%
2 Consumer Discretionary 15.48%
3 Technology 15.29%
4 Communication Services 11.15%
5 Healthcare 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NNVC icon
1101
NanoViricides
NNVC
$31.7M
$118 ﹤0.01%
7
– –
FAZ
1102
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
– –
0
– –
ADXS
1103
DELISTED
Advaxis Inc
ADXS
$101 ﹤0.01%
4
– –
CRIS icon
1104
Curis
CRIS
$3.61M
– –
0
– –
SNOA icon
1105
Sonoma Pharmaceuticals
SNOA
$6.27M
– –
0
– –
FTR
1106
DELISTED
Frontier Communications Corp.
FTR
$89 ﹤0.01%
12
– –
GTE icon
1107
Gran Tierra Energy
GTE
$349M
$84 ﹤0.01%
3
– –
GENE
1108
DELISTED
Genetic Technologies Ltd.
GENE
$83 ﹤0.01%
4
– –
TPST icon
1109
Tempest Therapeutics
TPST
$17.5M
– –
0
– –
VIVE
1110
DELISTED
VIVEVE MED INC
VIVE
– –
0
– –
FRO icon
1111
Frontline
FRO
$9.84B
$62 ﹤0.01%
14
– –
LSTA icon
1112
Lisata Therapeutics
LSTA
$15.2M
$58 ﹤0.01%
1
– –
VIAV icon
1113
Viavi Solutions
VIAV
$9.02B
$58 ﹤0.01%
6
– –
GCVRZ
1114
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$55 ﹤0.01%
130
– –
SRL icon
1115
Scully Royalty
SRL
$88.9M
$50 ﹤0.01%
8
– –
FCSC
1116
DELISTED
Fibrocell Science Inc.
FCSC
$40 ﹤0.01%
13
– –
GRCE
1117
Grace Therapeutics
GRCE
$44.6M
$31 ﹤0.01%
1
– –
CYTR
1118
DELISTED
CytRx Corp
CYTR
$27 ﹤0.01%
17
– –
PALI icon
1119
Palisade Bio
PALI
$349M
– –
0
– –
OIBR.C
1120
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$24 ﹤0.01%
4
– –
CDTI
1121
DELISTED
CDTI Advanced Materials, Inc. Common Stock
CDTI
$13 ﹤0.01%
3
– –
DRIO icon
1122
DarioHealth
DRIO
$66.3M
– –
0
– –
APEN
1123
DELISTED
Apollo Endosurgery, Inc.
APEN
$6 ﹤0.01%
1
– –
MBOT icon
1124
Microbot Medical
MBOT
$99.4M
– –
0
– –
IMUC
1125
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$1 ﹤0.01%
2
– –
43 44
45
46 47

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q1 2018 Portfolio in Review

As of Q1 2018, RBC Europe held 1,198 positions worth $817M, up 0.61% from $812M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

RBC Europe's Q1 2018 filing shows 61 new, 125 increased, 182 reduced and 72 closed positions. Its largest new stake was GeoPark: 114,276 shares worth $1.41M. The largest sale was Wells Fargo, an estimated $4.07M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q1 2018 buy was GeoPark: 114,276 shares worth $1.41M.
  • RBC Europe added most to JPMorgan Chase in Q1 2018, an estimated $3.72M increase.
  • RBC Europe's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $4.07M.
  • RBC Europe fully exited First Trust Alerian US NextGen Infrastructure ETF in Q1 2018, selling an estimated $613K.
  • RBC Europe's ten largest holdings make up 39% of its $817M portfolio in Q1 2018.
  • RBC Europe opened 61 new positions and closed 72 in Q1 2018.
  • RBC Europe's portfolio value rose 0.61% quarter-over-quarter to $817M.

Based on RBC Europe's 13F filing for Q1 2018, filed 9 Nov 2023.